Click image to enlarge
The
U-PLEX platform offers validated components that can be combined to create high quality assays quickly and easily. The U-PLEX Human Leptin Antibody Set is a matched pair of antibodies that can be used (with other U-PLEX components such as plates, calibrators, diluents, and MSD GOLD Read Buffer B) to build U-PLEX assays that measure Leptin. These assays can measure Leptin alone or in multiplex panels with other biomarkers. The Product Inserts in the “Documentation” tab (below) provide detailed instructions for building assays with U-PLEX Antibody Sets.
For information on multiplexing Leptin with other analytes, please see
U-PLEX Metabolic Group 1 (hu) Assays or
U-PLEX Immuno-Oncology Group 1 (hu) Assays.
-
Specifications
-
-
Kit Contents
-
Documentation
-
References
Analyte(s)
|
|
Leptin
|
|
Species
|
|
Human
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
2-8 °C
|
|
Gene ID(s)
|
|
3952
|
|
UniProt ID(s)
|
|
P41159
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human Leptin Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
SULFO-TAG Human Leptin Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human Leptin Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
SULFO-TAG Human Leptin Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Leptin levels are associated with multiple sclerosis risk
|
|
|
|
Genetic Deletion and Pharmacological Inhibition of Phosphodiesterase 10A Protects Mice From Diet-Induced Obesity and Insulin Resistance.
|
|
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
|
|
|
|
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters